Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
979
datasets available to search
ShareScore release 0.9.0
Dataset results
979 results for “HR”
Famitinib Plus SHR6390 and Endocrine Therapy in the Treatment of HR-positive, HER2-negative Advanced Breast Cancer
ClinicalTrials.gov study NCT05176080. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Comparative Effects of Mild and Moderate Aerobic Exercises on BP, VO2 and HR in Hypertensive Patients
ClinicalTrials.gov study NCT05409456. IPD Sharing: NO. Countries: 1. Publications: 9.
Adebrelimab Combined With Dalpiciclib and Standard Endocrine Therapy for HR + / HER2- Breast Cancer
ClinicalTrials.gov study NCT06599216. IPD Sharing: UNDECIDED. Countries: 1. Publications: 19.
A Study of SHR6390 in Combination With Letrozole or Anastrozole or Fulvestrant in Patients With HR Positive and HER2 Negative Advanced Breast Cancer
ClinicalTrials.gov study NCT03481998. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
Gedatolisib Plus Fulvestrant With or Without Palbociclib vs Standard-of-Care for the Treatment of Patients With Advanced or Metastatic HR+/HER2- Breast Cancer (VIKTORIA-1)
ClinicalTrials.gov study NCT05501886. IPD Sharing: Not stated. Countries: 23. Publications: 0.
NB2013-HR German (GPOH) / Dutch (DCOG) Trial
ClinicalTrials.gov study NCT02641782. IPD Sharing: NO. Countries: 1. Publications: 3.
Sacituzumab Govitecan +/- Pembrolizumab In HR+ / HER2 - MBC
ClinicalTrials.gov study NCT04448886. IPD Sharing: YES. Countries: 1. Publications: 0.
To Evaluate the Efficacy and Safety of TQB3616 in Combination With Fulvestrant Versus Placebo in Combination With Fulvestrant in Previously Untreated Hormone-receptor (HR)-Positive, Human Epidermal Gr
ClinicalTrials.gov study NCT05365178. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Blinatumomab as a Bridge to Allo-HSCT in HR BCP-ALL
ClinicalTrials.gov study NCT05559450. IPD Sharing: NO. Countries: 1. Publications: 1.
HOPE: Olaparib, Palbociclib and Fulvestrant in Patients With BRCA Mutation-associated, HR+, HER2-metastatic Breast Cancer
ClinicalTrials.gov study NCT03685331. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
A Study of Palbociclib With Exemestane Plus GnRH Versus Capecitabine in Premenopausal Women With HR+ MBC
ClinicalTrials.gov study NCT02592746. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Pilot Study of CC 486 (Oral Azacitidine) Plus BSC as Maintenance After sc Azacitidine in Elderly HR-IPSS-R MDS Patients
ClinicalTrials.gov study NCT04806906. IPD Sharing: Not stated. Countries: 1. Publications: 43.
Filling Bone Erosions: a Longitudinal Multicentric HR-pQCT Study of Subcutaneous Tocilizumab in Rheumatoid Arthritis
ClinicalTrials.gov study NCT02765074. IPD Sharing: NO. Countries: 1. Publications: 10.
Metronomic Capecitabine Plus Aromatase Inhibitor for First Line Treatment in HR(+), Her2(-) Metastatic Breast Cancer
ClinicalTrials.gov study NCT02767661. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
First-line Palbociclib and Endocrine Therapy for Patients With HR+/HER2- Advanced Breast Cancer in the Real-world Setting.
ClinicalTrials.gov study NCT04767594. IPD Sharing: NO. Countries: 2. Publications: 1.
HR-HPV Multi-site Opportunistic Screening in Liaoning, China
ClinicalTrials.gov study NCT03178136. IPD Sharing: NO. Countries: 1. Publications: 4.
HR Versus RFA for Early Stage HCC
ClinicalTrials.gov study NCT02169765. IPD Sharing: Not stated. Countries: 1. Publications: 5.
Quality of Life in Chinese Postmenopausal HR(+) Early Breast Cancer (EBC) Patients During Adjuvant Aromatase Inhibitors(AIs) Treatment
ClinicalTrials.gov study NCT01144572. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Prospective Study of the Prosigna Assay on Neoadjuvant Clinical Decision-making in Women With HR+/Her2- Breast Cancer
ClinicalTrials.gov study NCT03749421. IPD Sharing: NO. Countries: 1. Publications: 1.
Fulvestrant or Capecitabine Combined With Pyrotinib in HR+/HER2+ Metastatic Breast Cancer
ClinicalTrials.gov study NCT04646759. IPD Sharing: NO. Countries: 1. Publications: 7.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.